
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES183
One RCT287 comparing different doses of simvastatin (simvastatin 40 and 80 mg) concluded that no drug related serious clinical AEs were observed in the treatment groups. However, the study reported that two patients on simvastatin 80 mg treatment had an Alanine Transaminase (ALT) and Asparte Transaminase (AST) level >3 times the upper limit of normal; one of these patients was discontinued because of these elevations (the liver function tests returned to normal after discontinuation of the therapy). Level 1+

[@Miller_2004]

